Cargando…

Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes

Nonalcoholic fatty liver disease (NAFLD), the most widespread chronic liver disease worldwide, confers a significant burden on health systems and leads to increased mortality and morbidity through several extrahepatic complications. NAFLD comprises a broad spectrum of liver-related disorders, includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsamos, Georgios, Vasdeki, Dimitra, Koufakis, Theocharis, Michou, Vassiliki, Makedou, Kali, Tzimagiorgis, Georgios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141666/ https://www.ncbi.nlm.nih.gov/pubmed/37110175 http://dx.doi.org/10.3390/metabo13040517

Ejemplares similares

Remission as an Emerging Therapeutic Target in Type 2 Diabetes in the Era of New Glucose-Lowering Agents: Benefits, Challenges, and Treatment Approaches
por: Vasdeki, Dimitra, et al.
Publicado: (2022)

Effects of Christian Orthodox Fasting Versus Time-Restricted Eating on Plasma Irisin Concentrations Among Overweight Metabolically Healthy Individuals
por: Karras, Spyridon N., et al.
Publicado: (2021)

Effects of Home-Based Exercise Training on Cardiac Autonomic Neuropathy and Metabolic Profile in Diabetic Hemodialysis Patients
por: Michou, Vassiliki, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease severity, central fat mass and adinopectin: a close relationship
por: ABENAVOLI, LUDOVICO, et al.
Publicado: (2015)

Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE((-/-)) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
por: Nasiri-Ansari, Narjes, et al.
Publicado: (2021)

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
por: Hallsworth, Kate, et al.
Publicado: (2011)

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
por: Orešič, Matej, et al.
Publicado: (2013)

How Far beyond Diabetes Can the Benefits of Glucagon-like Peptide-1 Receptor Agonists Go? A Review of the Evidence on Their Effects on Hepatocellular Carcinoma
por: Arvanitakis, Konstantinos, et al.
Publicado: (2022)

A study of non-alcoholic fatty liver disease-liver fat score in overweight and obese individuals
por: Koneru, Kavya, et al.
Publicado: (2022)

The Calculation and Evaluation of an Ultrasound-Estimated Fat Fraction in Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease
por: Kaposi, Pál Novák, et al.
Publicado: (2023)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

Emerging Diagnostics and Therapeutics for Non-alcoholic Fatty Liver Disease
por: Darbhanga, Jake, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar?
por: Longato, Lisa
Publicado: (2013)

Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches
por: Arvanitakis, Konstantinos, et al.
Publicado: (2023)

Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) – an 11-Year Prospective Study
por: Lallukka, Susanna, et al.
Publicado: (2017)

The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease
por: Pokharel, Arbinda, et al.
Publicado: (2021)

Metabolic abnormalities, liver and body fat in American versus Chinese patients with non‐alcoholic fatty liver disease
por: Zhang, Wei, et al.
Publicado: (2022)

Association between smoking cessation and non-alcoholic fatty liver disease using NAFLD liver fat score
por: Jang, Yun Seo, et al.
Publicado: (2023)

Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers
por: Shafiha, Roshan, et al.
Publicado: (2021)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications
por: Klujszo, Elzbieta H., et al.
Publicado: (2019)

The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease
por: Filipovic, Branka, et al.
Publicado: (2021)

Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease
por: Teng, Tieshan, et al.
Publicado: (2022)

The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
por: Liu, Qing, et al.
Publicado: (2010)

Bone marrow fat change in pediatric patients with non-alcoholic fatty liver disease
por: Albakheet, Salman S., et al.
Publicado: (2020)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease
por: Maldonado, Elaina M., et al.
Publicado: (2018)

Reducing Liver Fat by Low Carbohydrate Caloric Restriction Targets Hepatic Glucose Production in Non-Diabetic Obese Adults with Non-Alcoholic Fatty Liver Disease
por: Yu, Haoyong, et al.
Publicado: (2014)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
por: Martínez–Sánchez, Celia, et al.
Publicado: (2023)

Dietary capsaicin and antibiotics act synergistically to reduce non-alcoholic fatty liver disease induced by high fat diet in mice
por: Hu, Jingjuan, et al.
Publicado: (2017)

Changes in dietary intake of aspartic acid during and after intermittent fasting correlate with an improvement in fasting glucose in overweight individuals
por: Karras, Spyridon N., et al.
Publicado: (2023)

Bariatric Metabolic Surgery Reduced Liver Enzyme Levels in Patients with Non-Alcohol Fatty Liver Disease
por: Kirkpatrick, Kennedy, et al.
Publicado: (2021)

Close association between non-alcoholic fatty liver disease and ossification of the posterior longitudinal ligament of the spine
por: Endo, Tsutomu, et al.
Publicado: (2021)

Molecular mechanism of alcoholic fatty liver
por: Rasineni, Karuna, et al.
Publicado: (2012)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Lipophagy and Alcohol-Induced Fatty Liver
por: Yang, Li, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ate8n1mekc7gnaf47q70m39po2